Michael Townsend, PhD

Dr. Michael Townsend is Vice President, Head of Translational Biology at TRexBio.

Prior to joining the company, he held positions of increasing responsibility over 18 years at Genentech working across a broad range of therapeutic areas and indications while leading a translational research department focused on disease mechanisms, biomarker discovery, and reverse translation. He has supported biomarker discovery, biomarker strategy development, and clinical implementation across all phases of drug development. Dr. Townsend has contributed to multiple IND filings, has co-authored over 50 primary research papers and review articles, and is an inventor on five patents.

Dr. Townsend received his BSc in Biochemistry from Imperial College London and his PhD in Immunology and Molecular Biology from the University of Cambridge. He carried out postdoctoral research in the laboratory of Laurie Glimcher, MD, at the Harvard School of Public Health.